Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCentral nervous system medication use and incident mobility limitation in community elders: the health, aging, and body composition study
Pharmacoepidemiology and Drug Safety, 09/10/09
Boudreau RM et al. – CNS medication use is independently associated with an increased risk of future incident mobility limitation in community dwelling elderly. Further studies are needed to determine the impact of reducing CNS medication exposure on mobility problems.
Related Articles
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: A randomised phase 2 trial
The Lancet, 11/05/09
Relevance Score: 89%
Evolution of the human CNS cholineric system: has this resulted in the emergence of psychiatric disease
Australian and New Zealand Journal of Psychiatry, 11/03/09
Relevance Score: 87%
Current Challenges in Glia-Pain Biology
Neuron, 10/22/09
Relevance Score: 87%
Evolving role of laminin receptors in microbial pathogenesis and therapeutics of CNS infection
Future Microbiology, 10/16/09
Relevance Score: 87%
Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status
Journal of Neuro-Oncology, 10/27/09
Relevance Score: 85%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
Current Drug Targets, 12/10/09
Durability of Therapeutic Response to Milnacipran Treatment for Fibromyalgia. Results of a Randomized, Double-Blind, Monotherapy 6-Month Extension Study
Pain Medicine, 12/10/09
An Open Pilot Study Assessing the Benefits of Quetiapine for the Prevention of Migraine Refractory to the Combination of Atenolol, Nortriptyline, and Flunarizine
Pain Medicine, 12/10/09
Sponsor
Article Search
Sponsor